MicroRNA-26a negatively regulates toll-like receptor 3 expression of rat macrophages and ameliorates pristane induced arthritis in rats

Arthritis Research and Therapy

Volumn 16, Issue 1, 2014, Pages

  Jiang, Congshan ^a,b   Zhu, Wenhua ^a,b   Xu, Jing ^a,b   Wang, Bo ^a,b   Hou, Weikun ^a   Zhang, Rui ^a   Zhong, Nannan ^a,b   Ning, Qilan ^a,b   Han, Yan ^a,b   Yu, Hongchuan ^c   Sun, Jian ^a,b   Meng, Liesu ^a,b   Lu, Shemin ^a,b  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c XI AN CHILDREN S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; MESSENGER RNA; METHOTREXATE; MICRORNA 26A; PRISTANE; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR; IMMUNOSUPPRESSIVE AGENT; MICRORNA; MIRN26 MICRORNA, RAT; TERPENE; TLR3 PROTEIN, RAT;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DEFENSE MECHANISM; DEPRESSION; DISEASE SEVERITY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; EXPERIMENTAL ARTHRITIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; GENE EXPRESSION REGULATION; IMMUNOSUPPRESSIVE AGENTS; MACROPHAGES; MICRORNAS; RATS; REAL-TIME POLYMERASE CHAIN REACTION; TERPENES; TOLL-LIKE RECEPTOR 3;

EID: 84892374785     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4435     Document Type: Article

References (42)

1. Keogh B, Parker AE. Toll-like receptors as targets for immune disorders. Trends Pharmacol Sci 2011, 32:435-442. 10.1016/j.tips.2011.03.008, 21529972.
2. Netea MG, Wijmenga C, O'Neill LA. Genetic variation in Toll-like receptors and disease susceptibility. Nat Immunol 2012, 13:535-542. 10.1038/ni.2284, 22610250.
3. Yu M, Levine SJ. Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses. Cytokine Growth Factor Rev 2011, 22:63-72. 10.1016/j.cytogfr.2011.02.001, 3109132, 21466970.
4. Beutler ALBAB. Intracelluar Toll-like receptors. Immunity 2010, 32:305-315. 10.1016/j.immuni.2010.03.012, 20346772.
5. Botos I, Segal DM, Davies DR. The structural biology of Toll-like receptors. Structure 2012, 19:447-459.
6. Ospelt C, Brentano F, Rengel Y, Stanczyk J, Kolling C, Tak PP, Gay RE, Gay S, Kyburz D. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum 2008, 58:3684-3692. 10.1002/art.24140, 19035519.
7. Roelofs MF, Joosten LA, Abdollahi-Roodsaz S, van Lieshout AW, Sprong T, Van Den Hoogen FH, Van Den Berg WB, Radstake TR. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum 2005, 52:2313-2322. 10.1002/art.21278, 16052591.
8. Brentano F, Schorr O, Gay RE, Gay S, Kyburz D. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis Rheum 2005, 52:2656-2665. 10.1002/art.21273, 16142732.
9. Bombardieri M, Kam NW, Brentano F, Choi K, Filer A, Kyburz D, McInnes IB, Gay S, Buckley C, Pitzalis C. A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells. Ann Rheum Dis 2011, 70:1857-1865. 10.1136/ard.2011.150219, 21798884.
10. Meng L, Zhu W, Jiang C, He X, Hou W, Zheng F, Holmdahl R, Lu S. Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats. Arthritis Res Ther 2010, 12:R103. 10.1186/ar3034, 2911891, 20500834.
11. Zhu W, Meng L, Jiang C, Xu J, Wang B, Han Y, Lu S. Overexpression of toll-like receptor 3 in spleen is associated with experimental arthritis in rats. Scand J Immunol 2012, 76:263-270. 10.1111/j.1365-3083.2012.02724.x, 22702720.
12. Zhu W, Meng L, Jiang C, He X, Hou W, Xu P, Heng D, Holmdahl R, Lu S. Arthritis is associated with a T cell induced upregulation of toll-like receptor (TLR) 3 on synovial fibroblasts. Arthritis Res Ther 2011, 13:R103. 10.1186/ar3384, 3218918, 21708001.
13. O'Mahony DS, Pham U, Iyer R, Hawn TR, Liles WC. Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages. Int J Med Sci 2008, 5:1-8. 2204042, 18219369.
14. Meyer C, Pries R, Wollenberg B. Established and novel NF-kappaB inhibitors lead to downregulation of TLR3 and the proliferation and cytokine secretion in HNSCC. Oral Oncol 2011, 47:818-826. 10.1016/j.oraloncology.2011.06.010, 21745758.
15. Tao S, Zhu L, Lee P, Lee WM, Knox K, Chen J, Di YP, Chen Y. Negative control of TLR3 signaling by TICAM1 down-regulation. Am J Respiratory Cell Mole Biol 2012, 46:660-667.
16. Zhao J, Benakanakere MR, Hosur KB, Galicia JC, Martin M, Kinane DF. Mammalian target of rapamycin (mTOR) regulates TLR3 induced cytokines in human oral keratinocytes. Mole Immunol 2010, 48:294-304.
17. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233. 10.1016/j.cell.2009.01.002, 3794896, 19167326.
18. O'Neill LA, Sheedy FJ, McCoy CE. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 2011, 11:163-175. 10.1038/nri2957, 21331081.
19. Chen Q, Wang H, Liu Y, Song Y, Lai L, Han Q, Cao X, Wang Q. Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1beta production in macrophages by targeting STAT3. PloS one 2012, 7:e42971. 10.1371/journal.pone.0042971, 3427313, 22937006.
20. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006, 103:12481-12486. 10.1073/pnas.0605298103, 1567904, 16885212.
21. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20. 10.1016/j.cell.2004.12.035, 15652477.
22. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res 2008, 36:D149-D153. 2238905, 18158296.
23. Betel D, Koppal A, Agius P, Sander C, Leslie C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 2010, 11:R90. 10.1186/gb-2010-11-8-r90, 2945792, 20799968.
24. Weischenfeldt J, Porse B. Bone marrow-derived macrophages (BMM): isolation and applications. CSH Protocols 2008, 2008. pdb prot5080.
25. Vingsbo C, Sahlstrand P, Brun JG, Jonsson R, Saxne T, Holmdahl R. Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol 1996, 149:1675-1683. 1865278, 8909256.
26. Hultqvist M, Olofsson P, Gelderman KA, Holmberg J, Holmdahl R. A new arthritis therapy with oxidative burst inducers. PLoS Med 2006, 3:e348. 10.1371/journal.pmed.0030348, 1564167, 16968121.
27. Yang X, Sun Q, Asim MB, Jiang X, Zhong B, Shahzad M, Zhang F, Han Y, Lu S. Nitric oxide in both bronchoalveolar lavage fluid and serum is associated with pathogenesis and severity of antigen-induced pulmonary inflammation in rats. J Asthma 2010, 47:135-144. 10.3109/02770900903483808, 20170319.
28. [http://www.microRNA.org].
29. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006, 34:D140-D144. 10.1093/nar/gkj112, 1347474, 16381832.
30. Linsen SE, de Wit E, de Bruijn E, Cuppen E. Small RNA expression and strain specificity in the rat. BMC Genomics 2010, 11:249. 10.1186/1471-2164-11-249, 2864251, 20403161.
31. Sun J, Zhong N, Li Q, Min Z, Zhao W, Sun Q, Tian L, Yu H, Shi Q, Zhang F, Lu S. MicroRNAs of rat articular cartilage at different developmental stages identified by Solexa sequencing. Osteoarthritis Cartilage 2011, 19:1237-1245. 10.1016/j.joca.2011.07.002, 21820522.
32. Zhou J, Ju W, Wang D, Wu L, Zhu X, Guo Z, He X. Down-regulation of microRNA-26a promotes mouse hepatocyte proliferation during liver regeneration. PloS one 2012, 7:e33577. 10.1371/journal.pone.0033577, 3319545, 22496754.
33. Luzi E, Marini F, Sala SC, Tognarini I, Galli G, Brandi ML. Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res 2008, 23:287-295.
34. Wong CF, Tellam RL. MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis. J Biol Chem 2008, 283:9836-9843. 10.1074/jbc.M709614200, 18281287.
35. Sander S, Bullinger L, Klapproth K, Fiedler K, Kestler HA, Barth TF, Moller P, Stilgenbauer S, Pollack JR, Wirth T. MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood 2008, 112:4202-4212. 10.1182/blood-2008-03-147645, 18713946.
36. Ichikawa T, Sato F, Terasawa K, Tsuchiya S, Toi M, Tsujimoto G, Shimizu K. Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells. PLoS One 2012, 7:e31422. 10.1371/journal.pone.0031422, 3288043, 22384020.
37. Mohamed JS, Lopez MA, Boriek AM. Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3beta. J Biol Chem 2010, 285:29336-29347. 10.1074/jbc.M110.101147, 2937966, 20525681.
38. Luzi E, Marini F, Tognarini I, Galli G, Falchetti A, Brandi ML. The regulatory network menin-microRNA 26a as a possible target for RNA-based therapy of bone diseases. Nucleic Acid Ther 2012, 22:103-108.
39. Brentano F, Kyburz D, Gay S. Toll-like receptors and rheumatoid arthritis. Methods Mole Biol (Clifton, NJ) 2009, 517:329-343.
40. Roelofs MF, Wenink MH, Brentano F, Abdollahi-Roodsaz S, Oppers-Walgreen B, Barrera P, van Riel PL, Joosten LA, Kyburz D, Van Den Berg WB, Radstake TR. Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA). Ann Rheum Dis 2009, 68:1486-1493. 10.1136/ard.2007.086421, 18765427.
41. Goh FG, Midwood KS. Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis. Rheumatology (Oxford) 2011, 51:7-23.
42. Ebert MS, Sharp PA. Roles for MicroRNAs in conferring robustness to biological processes. Cell 2012, 149:515-524. 10.1016/j.cell.2012.04.005, 3351105, 22541426.